THE FEATURES OF REALIZATION OF REPLACMENT HORMONAL THERAPY IN WOMEN WITH METABOLIC SYNDROME AND DISHORMONAL DISORDERS OF MAMMARY GLAND
Abstract
The usage of Femoston is optimal for realization of substitutive replacment therapy in patients with metabolic syndrome and diffuse dishormonal disorders of mammary gland was founded. The Femoston application has decreased clinical symptoms of climacteric disorders and allowed to control metabolic and cardiovascular pathology. The usage of Femoston gives to correct effects of hypoestrogenemia and comparative hyperandrogenemia on the mammary gland, prophylaxis of cancer. The high effectiveness of Femoston to combine with absence of incidental reactions.
Downloads
References
2. Ласочко С.А. // Нова медицина. - 2004. - № 3. - С. 73-75.
3. Новикова Е.Г., Сметник В.П., Новикова О.В. // Рос. онкол. журн. - 1999. - № 5. - С. 43-48.
4. Татарчук Т.Ф. // Здоровье женщины. - 2002. - № 4. - С. 34-35.
5. Татарчук ТФ., Єфименко О.О., Бурлака О.А., и др. // Здоровье женщины. - 2001. - № 2. - С. 21-26.
6. Урманчеева А.Ф., Бурнина М.М. // Леч. врач. - 2000. - № 5-6. - С. 34-37.
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.